SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-024503
Filing Date
2018-04-17
Accepted
2018-04-17 16:02:00
Documents
5
Period of Report
2018-04-13
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-10090_18k.htm 8-K 29559
2 EX-99.1 a18-10090_1ex99d1.htm EX-99.1 13179
3 EX-99.2 a18-10090_1ex99d2.htm EX-99.2 1584
4 GRAPHIC g100901moi001.gif GRAPHIC 132893
5 GRAPHIC g100901mmi001.jpg GRAPHIC 2548
  Complete submission text file 0001104659-18-024503.txt   232346
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 18758998
SIC: 2834 Pharmaceutical Preparations